Thus, deciphering the relationship between DDX56 expression and its impact on the prognosis for HCC patients as well as its direct effect on hepatocarcinogenesis may reveal novel diagnostic and therapeutic targets. This evidence concerns the gene DDX56 and hepatocellular carcinoma.